US Patent:
20020098182, Jul 25, 2002
Inventors:
Richard Weisbart - Los Angeles CA, US
Leon Barstow - Tucson AZ, US
International Classification:
A61K039/395
Abstract:
Human plasma fractions substantially enriched in human immunoglobulin G, such as Cohn Fraction II+III, and optionally an antacid may be administered orally to patients suffering from a myriad of immune-mediated diseases, including rheumatoid arthritis, to treat the disease condition of those patients. Oral administration of Cohn Fraction II+III results in significant clinical improvement in the level of disease activity in patients with rheumatoid arthritis, for example.